Research programme: cannabinoid based therapeutics - Lara PharmaceuticalsAlternative Names: LP-306
Latest Information Update: 17 Oct 2014
At a glance
- Originator LaraPharm
- Class Cannabinoids; Non-opioid analgesics; Small molecules
- Mechanism of Action Cannabinoid receptor CB1 agonists; Cannabinoid receptor CB2 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Pain
Most Recent Events
- 01 Apr 2014 Early research in Pain in Israel (Inhalation)